Andrew Shaffer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrew Shaffer has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Ranjit John
5 shared publicationsMarshall Hertz
Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN
2 shared publicationsMatthew Soule
Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota Medical School, Minneapolis, MN
2 shared publicationsRebecca Cogswell
Division of Cardiology, Department of Medicine (V.M., B.B., F. Kazmirczak, J.M., T.A., C.M.M., R.C., F. Kamdar), University of Minnesota, Minneapolis
2 shared publicationsSara Shumway
Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota Medical School, Minneapolis, MN
2 shared publications- Stephen J. Huddleston
Division of Cardiothoracic Surgery, University of Minnesota, Minneapolis, MN
2 shared publications
Latest Publications
- Open Access
- 19 February 2026
- Published by Elsevier in JTCVS Open
- Vol. 31
The changing landscape of temporary mechanical circulatory support devices in the new heart allocation system: A US nationwide analysis
- 19 February 2026
- Published by Elsevier in JTCVS Open
- Vol. 31
Open AccessThe changing landscape of temporary mechanical circulatory support devices in the new heart allocation system: A US nationwide analysis
- Top Cited Papers
- 1 April 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (13) , 896-909
Clinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry
BACKGROUND: A preservation system, the Organ Care System (OCS; TransMedics) uses normothermic pulsatile perfusion during organ transport for heart transplantation. This system has demonstrated favorable outcomes in hearts recovered from extended-criteria donors after brain death (DBD) and donors after circulatory death (DCD). METHODS: The OCS Heart Perfusion Registry collects data on US heart transplantations using the OCS, static cold storage (SCS), or thoracoabdominal normothermic regional perfusion (NRP) and donor hearts recovered from DBD or DCD donors. We analyzed donor and recipient characteristics and posttransplantation outcomes in patients transplanted with OCS donor hearts (either DBD or DCD) compared with SCS hearts, and with OCS hearts from DCD donors compared with those recovered with NRP followed by SCS. Propensity score matching was used in survival analyses to adjust for differences among recipient characteristics. RESULTS: Between 2021 and 2023, 3225 consecutive heart transplantations enrolled from 56 centers were analyzed in the Heart Perfusion Registry. The OCS was used in 854 of 3225 heart transplantations (26.4%), among which 340 (39.8%) were DBD and 514 (60.2%) were DCD donors, whereas 2174 DBD donors were recovered with SCS and another 197 DCD donors with NRP techniques. The OCS-DBD group experienced a greater number of organ offer refusals before final acceptance (13 versus 6; Wilcoxon rank sum, P P P =0.54). Among the OCS-DCD and SCS-DBD groups, survival at 12 months was also similar (91.0% versus 92.5%, respectively; marginal Cox model, P =0.32). The OCS-DCD and NRP-DCD groups demonstrated similar survival (91.0% versus 91.7%, respectively; log rank, P =0.63), although the transport distance was longer in OCS-DCD compared with DCD with NRP followed by SCS (400 miles versus 223 miles; Wilcoxon rank sum, P <0.001). By 2023, 90% of all OCS donor management and recovery was performed with dedicated organ recovery teams. CONCLUSIONS: We demonstrate that real-world implementation of the OCS for DBD donors (using predominantly a dedicated recovery team) is associated with expanded donor criteria, longer transport distance, and excellent posttransplantation outcomes. In OCS-DCD donors, outcomes parallel those of donors recovered with NRP-DCD and compare favorably with DBD donor organs.
- 1 April 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 151 (13) , 896-909
Top Cited PapersClinical Outcomes With Normothermic Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry
BACKGROUND: A preservation system, the Organ Care System (OCS; TransMedics) uses normothermic pulsatile perfusion during organ transport for heart transplantation. This system has demonstrated favorable outcomes in hearts recovered from extended-criteria donors after brain death (DBD) and donors after circulatory death (DCD). METHODS: The OCS Heart Perfusion Registry collects data on US heart transplantations using the OCS, static cold storage (SCS), or thoracoabdominal normothermic regional perfusion (NRP) and donor hearts recovered from DBD or DCD donors. We analyzed donor and recipient characteristics and posttransplantation outcomes in patients transplanted with OCS donor hearts (either DBD or DCD) compared with SCS hearts, and with OCS hearts from DCD donors compared with those recovered with NRP followed by SCS. Propensity score matching was used in survival analyses to adjust for differences among recipient characteristics. RESULTS: Between 2021 and 2023, 3225 consecutive heart transplantations enrolled from 56 centers were analyzed in the Heart Perfusion Registry. The OCS was used in 854 of 3225 heart transplantations (26.4%), among which 340 (39.8%) were DBD and 514 (60.2%) were DCD donors, whereas 2174 DBD donors were recovered with SCS and another 197 DCD donors with NRP techniques. The OCS-DBD group experienced a greater number of organ offer refusals before final acceptance (13 versus 6; Wilcoxon rank sum, P P P =0.54). Among the OCS-DCD and SCS-DBD groups, survival at 12 months was also similar (91.0% versus 92.5%, respectively; marginal Cox model, P =0.32). The OCS-DCD and NRP-DCD groups demonstrated similar survival (91.0% versus 91.7%, respectively; log rank, P =0.63), although the transport distance was longer in OCS-DCD compared with DCD with NRP followed by SCS (400 miles versus 223 miles; Wilcoxon rank sum, P <0.001). By 2023, 90% of all OCS donor management and recovery was performed with dedicated organ recovery teams. CONCLUSIONS: We demonstrate that real-world implementation of the OCS for DBD donors (using predominantly a dedicated recovery team) is associated with expanded donor criteria, longer transport distance, and excellent posttransplantation outcomes. In OCS-DCD donors, outcomes parallel those of donors recovered with NRP-DCD and compare favorably with DBD donor organs.
- 9 December 2024
- Published by Springer Nature
- p. 745-772
Valvular Heart Disease
- 9 December 2024
- Published by Springer Nature
- p. 935-945
End-Stage Congestive Heart Failure in the Adult Population: Ventricular Assist Devices
- 9 December 2024
- Published by Springer Nature
- p. 935-945
End-Stage Congestive Heart Failure in the Adult Population: Ventricular Assist Devices
- 1 December 2021
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 14 (12) , e008334
Rapidly Progressive Left Ventricular Assist Device Outflow Graft Thrombosis Associated With COVID-19 Infection
- 1 December 2021
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 14 (12) , e008334
Rapidly Progressive Left Ventricular Assist Device Outflow Graft Thrombosis Associated With COVID-19 Infection
- 1 August 2021
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 162 (2) , 605-611
Future developments in left ventricular assist device therapy
- 1 August 2021
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 162 (2) , 605-611
Future developments in left ventricular assist device therapy
- 1 November 2020
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 34 (11) , 3013-3020
Separate Effect of Perioperative Recombinant Human Factor VIIa Administration and Packed Red Blood Cell Transfusions on Midterm Survival in Lung Transplantation Recipients
- 1 November 2020
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 34 (11) , 3013-3020
Separate Effect of Perioperative Recombinant Human Factor VIIa Administration and Packed Red Blood Cell Transfusions on Midterm Survival in Lung Transplantation Recipients
- 1 April 2020
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 66 (4) , 399-400
All Left Ventricular Device Bridges Can Lead to a Heart Transplant
- 1 April 2020
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 66 (4) , 399-400
All Left Ventricular Device Bridges Can Lead to a Heart Transplant
- 31 December 2019
- Published by Wiley in Clinical Transplantation
- Vol. 34 (1) , e13766
Need for tracheostomy after lung transplant predicts decreased mid‐ and long‐term survival
Background: Tracheostomy is an important adjunct for lung transplant patients requiring prolonged ventilation. We explored the effects of post‐transplant tracheostomy on survival and bronchiolitis obliterans syndrome after lung transplant.Methods: A retrospective, single center analysis was performed on all lung transplant recipients during the Lung Allocation Score (LAS) era. Risk factors for post‐transplant tracheostomy or death within 30 days were assessed. Kaplan‐Meier estimates and Cox proportional hazards models were used to examine the association between tracheostomy within 30 days after transplant and survival at 1 and 3 years. A total of 403 patients underwent single or bilateral lung transplant between May 2005 and February 2016 with complete data for 352 cases, and 35 patients (9.9%) underwent tracheostomy or died (N = 10, 2.8%) within 30 days.Results: In adjusted analyses, primary graft dysfunction grade 3 (PGD3) was associated with a composite end point of tracheostomy or death within 30 days (HR 3.11 (1.69, 5.71), P‐value < .001). Tracheostomy within 30 days was associated with decreased survival at 1(HR 4.25 [1.75, 10.35] P‐value = .001) and 3 years (HR 2.74 [1.30, 5.76], P‐value = .008), as well as decreased bronchiolitis obliterans (BOS)‐free survival at 1 (HR 1.87 [1.02, 3.41] P‐value = .042) and 3 years (HR 2.15 [1.33, 3.5], P‐value = .002).Conclusion: Post‐transplant tracheostomy is a marker for advanced lung allograft dysfunction with significant reduction in long‐term overall and BOS‐free survival.
- 31 December 2019
- Published by Wiley in Clinical Transplantation
- Vol. 34 (1) , e13766
Need for tracheostomy after lung transplant predicts decreased mid‐ and long‐term survival
Background: Tracheostomy is an important adjunct for lung transplant patients requiring prolonged ventilation. We explored the effects of post‐transplant tracheostomy on survival and bronchiolitis obliterans syndrome after lung transplant.Methods: A retrospective, single center analysis was performed on all lung transplant recipients during the Lung Allocation Score (LAS) era. Risk factors for post‐transplant tracheostomy or death within 30 days were assessed. Kaplan‐Meier estimates and Cox proportional hazards models were used to examine the association between tracheostomy within 30 days after transplant and survival at 1 and 3 years. A total of 403 patients underwent single or bilateral lung transplant between May 2005 and February 2016 with complete data for 352 cases, and 35 patients (9.9%) underwent tracheostomy or died (N = 10, 2.8%) within 30 days.Results: In adjusted analyses, primary graft dysfunction grade 3 (PGD3) was associated with a composite end point of tracheostomy or death within 30 days (HR 3.11 (1.69, 5.71), P‐value < .001). Tracheostomy within 30 days was associated with decreased survival at 1(HR 4.25 [1.75, 10.35] P‐value = .001) and 3 years (HR 2.74 [1.30, 5.76], P‐value = .008), as well as decreased bronchiolitis obliterans (BOS)‐free survival at 1 (HR 1.87 [1.02, 3.41] P‐value = .042) and 3 years (HR 2.15 [1.33, 3.5], P‐value = .002).Conclusion: Post‐transplant tracheostomy is a marker for advanced lung allograft dysfunction with significant reduction in long‐term overall and BOS‐free survival.
- Open Access
- 30 December 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (3) , 668-671
Multimodal functional and still imaging of a transplanted human heart reanimated using Visible Heart® methodologies
Background Our research team obtained a human heart with the right lung attached from a recent transplantation patient via a research collaboration with LifeSource, a local organ procurement organization. The heart and lungs were not viable for transplant given the patient's medical history and were subsequently offered to the University of Minnesota for research purposes. Methods Using Visible Heart® methodologies, we reanimated the specimen en bloc and collected multimodal direct visualization from inside the cardiac chambers and great vessels of the functioning heart. Results Video footage, using videoscopic and fluoroscopic imaging, was captured and is presented in this report as supporting material. Multiple still images highlight the surgical suture sites of the transplantation procedures. Conclusions This multimodal imaging offers unique educational value for medical students, clinicians, and medical device designers for improving transplantation techniques and patient outcomes.
- 30 December 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 35 (3) , 668-671
Open AccessMultimodal functional and still imaging of a transplanted human heart reanimated using Visible Heart® methodologies
Background Our research team obtained a human heart with the right lung attached from a recent transplantation patient via a research collaboration with LifeSource, a local organ procurement organization. The heart and lungs were not viable for transplant given the patient's medical history and were subsequently offered to the University of Minnesota for research purposes. Methods Using Visible Heart® methodologies, we reanimated the specimen en bloc and collected multimodal direct visualization from inside the cardiac chambers and great vessels of the functioning heart. Results Video footage, using videoscopic and fluoroscopic imaging, was captured and is presented in this report as supporting material. Multiple still images highlight the surgical suture sites of the transplantation procedures. Conclusions This multimodal imaging offers unique educational value for medical students, clinicians, and medical device designers for improving transplantation techniques and patient outcomes.